Literature DB >> 6933444

Both the 7-methyl and the 2'-O-methyl groups in the cap of mRNA strongly influence its ability to act as primer for influenza virus RNA transcription.

M Bouloy, S J Plotch, R M Krug.   

Abstract

The ability of eukaryotic mRNAs to serve as primers for influenza virus RNA transcription depends on the presence of a 5'-terminal methylated can structure, the absence of which eliminates essentially all priming activity [Plotch, S. J., Bouloy, M. & Krug, R. M. (1979) Proc. Natl. Acad. Sci. USA 76, 1618-1622]. The present study was undertaken to determine the extent to which each of the methyl groups in the cap influences the priming activity of a mRNA. To assess the importance of the 2'-O-methyl group on the penultimate base of the cap, we used several plant viral RNAs containing the monomethylated cap 0 structure, m7GpppG. Brome mosaic virus (BMV) RNA 4 stimulated influenza virus RNA transcription only about 10-15% as effectively as did globin mRNA, which has a cap with a 2'-O-methyl group. When the cap of BMV RNA 4 was enzymatically 2'-O-methylated, its priming activity was increased 14-fold. Qualitatively similar results were obtained with other plant virus RNAs. To assess the importance of the terminal 7-methyl group, BMV RNA 4 containing the cap structure GpppGm was prepared by a series of chemical and enzymatic steps. These molecules were found to be only about 15% as active in priming as BMV RNA 4 molecules containing the fully methylated cap, m7GpppGm, indicating that the terminal 7-methyl group also strongly enhances priming activity. These results indicate that the cap 1 structure (m7GpppXm) found in all mammalian cellular mRNAs is more stringently required for priming influenza virus RNA transcription than for translation in cell-free systems.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6933444      PMCID: PMC349745          DOI: 10.1073/pnas.77.7.3952

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Influenza viral mRNA contains internal N6-methyladenosine and 5'-terminal 7-methylguanosine in cap structures.

Authors:  R M Krug; M A Morgan; A J Shatkin
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

2.  Reovirus messenger RNA contains a methylated, blocked 5'-terminal structure: m-7G(5')ppp(5')G-MpCp-.

Authors:  Y Furuichi; M Morgan; S Muthukrishnan; A J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

3.  Methylated, blocked 5 termini in HeLa cell mRNA.

Authors:  Y Furuichi; M Morgan; A J Shatkin; W Jelinek; M Salditt-Georgieff; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

4.  Translational discrimination of 'capped' and 'non-capped' mRNAS: inhibition of a series of chemical analogs of m7GpppX.

Authors:  D Canaani; M Revel; Y Groner
Journal:  FEBS Lett       Date:  1976-05-01       Impact factor: 4.124

5.  Blocked 5' termini in brome mosaic virus RNA.

Authors:  R Dasgupta; F Harada; P Kaesberg
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

6.  The 5'-end groups of alfalfa mosaic virus RNAs are m7G5'ppp5'Gp.

Authors:  L Pinck
Journal:  FEBS Lett       Date:  1975-11-01       Impact factor: 4.124

7.  Inhibition of HeLa cell messenger RNA translation by 7-methylguanosine 5'-monophosphate.

Authors:  L A Weber; E R Feman; E D Hickey; M C Williams; C Baglioni
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

8.  Translation of brome mosaic viral ribonucleic acid in a cell-free system derived from wheat embryo.

Authors:  D S Shih; P Kaesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205

9.  Modification of RNA by mRNA guanylyltransferase and mRNA (guanine-7-)methyltransferase from vaccinia virions.

Authors:  S A Martin; B Moss
Journal:  J Biol Chem       Date:  1975-12-25       Impact factor: 5.157

10.  Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions.

Authors:  S A Martin; E Paoletti; B Moss
Journal:  J Biol Chem       Date:  1975-12-25       Impact factor: 5.157

View more
  41 in total

1.  Mutagenic analysis of the 5' arm of the influenza A virus virion RNA promoter defines the sequence requirements for endonuclease activity.

Authors:  M B Leahy; D C Pritlove; L L Poon; G G Brownlee
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  In vivo analysis of the TSWV cap-snatching mechanism: single base complementarity and primer length requirements.

Authors:  D Duijsings; R Kormelink; R Goldbach
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

3.  Signatures of host mRNA 5' terminus for efficient hantavirus cap snatching.

Authors:  Erdong Cheng; Mohammad A Mir
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

4.  In vitro polymerase activity of Thogoto virus: evidence for a unique cap-snatching mechanism in a tick-borne orthomyxovirus.

Authors:  M B Leahy; J T Dessens; P A Nuttall
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  The 2'-O-ribose methyltransferase for cap 1 of spliced leader RNA and U1 small nuclear RNA in Trypanosoma brucei.

Authors:  Jesse R Zamudio; Bidyottam Mittra; Silvie Foldynová-Trantírková; Gusti M Zeiner; Julius Lukes; Janusz M Bujnicki; Nancy R Sturm; David A Campbell
Journal:  Mol Cell Biol       Date:  2007-07-02       Impact factor: 4.272

6.  Direct analysis of the mini-exon donor RNA of Trypanosoma brucei: detection of a novel cap structure also present in messenger RNA.

Authors:  M S Freistadt; G A Cross; A D Branch; H D Robertson
Journal:  Nucleic Acids Res       Date:  1987-12-10       Impact factor: 16.971

7.  Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription.

Authors:  I Ulmanen; B A Broni; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

8.  Solid phase synthesis of 5'-diphosphorylated oligoribonucleotides and their conversion to capped m7Gppp-oligoribonucleotides for use as primers for influenza A virus RNA polymerase in vitro.

Authors:  G G Brownlee; E Fodor; D C Pritlove; K G Gould; J J Dalluge
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

9.  Recombinant influenza virus polymerase: requirement of both 5' and 3' viral ends for endonuclease activity.

Authors:  M Hagen; T D Chung; J A Butcher; M Krystal
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 10.  Influenza A: understanding the viral life cycle.

Authors:  Tasleem Samji
Journal:  Yale J Biol Med       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.